Mitchell J Daley
Overview
Explore the profile of Mitchell J Daley including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
231
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gamble K, Rose D, Chang S, Hodge E, Jaso T, Trust M, et al.
Hosp Pharm
. 2024 Apr;
58(6):575-583.
PMID: 38560541
Recent studies have established cefepime as an effective treatment option for AmpC beta-lactamase (AmpC) Enterobacterales; however, the efficacy of beta-lactam/beta-lactamase inhibitors is unclear. The objective of this study was to...
2.
Perceptions regarding vasopressin use and practices in septic shock, and cost containment strategies
Hammond D, Rech M, Daley M, Devlin J, Hodge E, Kooda K, et al.
J Am Coll Clin Pharm
. 2024 Jan;
2(3):257-267.
PMID: 38213315
Background: Clinician preferences and practices regarding appropriate vasopressin use in light of its increased acquisition cost secondary to rebranding has not been evaluated or described since the most recent iteration...
3.
Brickel K, Hodge E, Zavgorodnyaya D, Schroeder J, Brown L, Daley M
Ann Pharmacother
. 2023 Aug;
58(5):453-460.
PMID: 37606361
Background: Benzodiazepines are the gold standard for treatment of alcohol withdrawal, yet the selection of a preferred benzodiazepine is limited due to a lack of comparative studies. Objectives: The primary...
4.
Addison J, Daley M, Curran M, Hodge E
J Pharm Pract
. 2022 Oct;
37(2):271-278.
PMID: 36189765
The optimal agent for deep sedation in patients undergoing continuous infusion (CI) neuromuscular blocking agent (NMBA) use for acute respiratory distress syndrome (ARDS) is unknown. The purpose of this study...
5.
Cascone A, Daley M, Pan N, Padilla-Tolentino E, Milling T
Pharmacotherapy
. 2021 Apr;
41(6):501-507.
PMID: 33866591
Study Objectives: Current neurocritical care guidelines recommend 50 IU/kg four-factor prothrombin complex concentrate (4PCC) for factor Xa inhibitor (FXaI) reversal in intracranial hemorrhage (ICH) based on few clinical studies conducted...
6.
Maguire C, Agrawal D, Daley M, Douglass E, Rose D
Ann Pharmacother
. 2020 Nov;
55(7):902-913.
PMID: 33135457
Objective: To provide an overview of pathophysiological changes to the pancreas during infected necrotizing pancreatitis (INP), optimal drug properties needed to penetrate the pancreas, human and animal studies supporting the...
7.
Lat I, Paciullo C, Daley M, MacLaren R, Bolesta S, McCann J, et al.
Crit Care Med
. 2020 Aug;
48(9):e813-e834.
PMID: 32826496
Objectives: To provide a multiorganizational statement to update recommendations for critical care pharmacy practice and make recommendations for future practice. A position paper outlining critical care pharmacist activities was last...
8.
Lat I, Paciullo C, Daley M, MacLaren R, Bolesta S, McCann J, et al.
Crit Care Med
. 2020 Aug;
48(9):1375-1382.
PMID: 32826489
Objectives: Provide a multiorganizational statement to update the statement from a paper in 2000 about critical care pharmacy practice and makes recommendations for future practice. Design: The Society of Critical...
9.
Lat I, Paciullo C, Daley M, MacLaren R, Bolesta S, McCann J, et al.
Am J Health Syst Pharm
. 2020 Aug;
77(19):1619-1624.
PMID: 32814962
Objectives: Provide a multiorganizational statement to update the statement from a paper in 2000 about critical care pharmacy practice and make recommendations for future practice. Design: The Society of Critical...
10.
Zavgorodnyaya D, Knight T, Daley M, Teixeira P
Am J Health Syst Pharm
. 2020 Jan;
77(4):269-276.
PMID: 31930282
Purpose: Evidence on the use of antithrombotic pharmacotherapy in patients undergoing revascularization of lower extremities for symptomatic peripheral arterial disease (PAD) is reviewed. Summary: Individuals with PAD can experience leg...